InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Skovronsky Daniel, Director. Officer active across 2 companies, notably Myriad Genetics INC. Aggregated, 7 reports have been published. The latest transaction was disclosed on 2 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
017,275 shares0
Common Stock
SEC:0001628280-22-016219:0·
€5m22,581 shares@ €212.99750.0005% mcap100.0% of flow
Common Stock
SEC:0000059478-22-000052·
€5m22,581 shares@ €212.99750.0005% mcap50.0% of flow
Common Stock
SEC:0000059478-22-000052:0·
018,735 shares0
Common Stock
SEC:0000059478-22-000024·
018,735 shares0
Common Stock
SEC:0000059478-22-000024:0·
012,848 shares0
Common Stock
SEC:0000899243-21-022170·
012,848 shares0
Common Stock
SEC:0000899243-21-022170:0·
7 of 7 declarations
About Skovronsky Daniel
Daniel Skovronsky serves as a Director and Senior Vice President at Myriad Genetics Inc and Eli Lilly & Co. In this role, he participates in the governance of the companies and strategic decision-making. His experience in the biopharmaceutical sector allows him to make significant contributions to board discussions, ensuring that the companies remain aligned with their growth objectives.
